
    
      All adult recipients of a primary kidney transplant will be eligible. Subjects will have
      blood samples drawn from which we will isolate lymphocytes and analyze the Treg population
      based on surface markers as well as a functional assay. The measures of Treg function will be
      compared to outcomes including DGF, graft survival and graft function, as well as the
      development of immunological complications such as donor-specific antibody production, acute
      rejection, IFTA and opportunistic infection.
    
  